EDSA

Edesa Biotech, Inc. Common Shares

1.51

USD

EDSA Earnings Reports

Positive Surprise Ratio

EDSA beat 19 of 29 last estimates.

66%

Next Report

Date of Next Report

Feb 12, 2026

Estimate for Q1 26 (Revenue/ EPS)

-$0.28

Implied change from Q4 25 (Revenue/ EPS)

-12.50%

Implied change from Q1 25 (Revenue/ EPS)

-41.67%

Edesa Biotech, Inc. Common Shares earnings per share and revenue

On Dec 12, 2025, EDSA reported earnings of -0.32 USD per share (EPS) for Q4 25, missing the estimate of -0.27 USD, resulting in a -17.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -16.09% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an decrease of -12.50% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Edesa Biotech, Inc. Common Shares's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Edesa Biotech, Inc. Common Shares reported EPS of -$0.32, missing estimates by -17.65%, and revenue of $0.00, 0% as expectations.

How did the market react to Edesa Biotech, Inc. Common Shares's Q4 2025 earnings?

The stock price moved down -16.09%, changed from $1.74 before the earnings release to $1.46 the day after.

When is Edesa Biotech, Inc. Common Shares expected to report next?

The next earning report is scheduled for Feb 12, 2026.

What are the forecasts for Edesa Biotech, Inc. Common Shares's next earnings report?

Based on 4 analysts, Edesa Biotech, Inc. Common Shares is expected to report EPS of -$0.28 and revenue of -- for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.